Logo image of CDAY.CA

CERIDIAN HCM HOLDING INC (CDAY.CA) Stock Fundamental Analysis

TSX:CDAY - Toronto Stock Exchange - US15677J1088 - Common Stock - Currency: CAD

92.28  +0.34 (+0.37%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to CDAY. CDAY was compared to 6 industry peers in the Professional Services industry. While CDAY is still in line with the averages on profitability rating, there are concerns on its financial health. CDAY is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CDAY had positive earnings in the past year.
In the past year CDAY had a positive cash flow from operations.
In the past 5 years CDAY reported 4 times negative net income.
Of the past 5 years CDAY 4 years had a positive operating cash flow.
CDAY.CA Yearly Net Income VS EBIT VS OCF VS FCFCDAY.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 50M -50M 100M -100M

1.2 Ratios

CDAY has a Return On Assets of 0.04%. This is in the better half of the industry: CDAY outperforms 62.50% of its industry peers.
CDAY has a better Return On Equity (0.18%) than 62.50% of its industry peers.
The Return On Invested Capital of CDAY (2.29%) is better than 62.50% of its industry peers.
Industry RankSector Rank
ROA 0.04%
ROE 0.18%
ROIC 2.29%
ROA(3y)-0.66%
ROA(5y)-0.4%
ROE(3y)-2.35%
ROE(5y)-1.42%
ROIC(3y)N/A
ROIC(5y)N/A
CDAY.CA Yearly ROA, ROE, ROICCDAY.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 0 -5 -10

1.3 Margins

The Profit Margin of CDAY (0.28%) is better than 62.50% of its industry peers.
CDAY has a better Operating Margin (7.74%) than 62.50% of its industry peers.
CDAY has a worse Gross Margin (42.19%) than 62.50% of its industry peers.
CDAY's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 7.74%
PM (TTM) 0.28%
GM 42.19%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.28%
GM growth 5Y-0.66%
CDAY.CA Yearly Profit, Operating, Gross MarginsCDAY.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 0 10 -10 20 30 40

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so CDAY is destroying value.
CDAY has more shares outstanding than it did 1 year ago.
Compared to 1 year ago, CDAY has an improved debt to assets ratio.
CDAY.CA Yearly Shares OutstandingCDAY.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 50M 100M 150M
CDAY.CA Yearly Total Debt VS Total AssetsCDAY.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2B 4B 6B 8B

2.2 Solvency

CDAY has an Altman-Z score of 1.17. This is a bad value and indicates that CDAY is not financially healthy and even has some risk of bankruptcy.
CDAY's Altman-Z score of 1.17 is on the low side compared to the rest of the industry. CDAY is outperformed by 62.50% of its industry peers.
CDAY has a debt to FCF ratio of 22.77. This is a negative value and a sign of low solvency as CDAY would need 22.77 years to pay back of all of its debts.
CDAY has a Debt to FCF ratio of 22.77. This is comparable to the rest of the industry: CDAY outperforms 50.00% of its industry peers.
A Debt/Equity ratio of 0.53 indicates that CDAY is somewhat dependend on debt financing.
CDAY has a worse Debt to Equity ratio (0.53) than 62.50% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 22.77
Altman-Z 1.17
ROIC/WACC0.28
WACC8.14%
CDAY.CA Yearly LT Debt VS Equity VS FCFCDAY.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 1.09 indicates that CDAY should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.09, CDAY is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
CDAY has a Quick Ratio of 1.09. This is a normal value and indicates that CDAY is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 1.09, CDAY is in the better half of the industry, outperforming 62.50% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.09
Quick Ratio 1.09
CDAY.CA Yearly Current Assets VS Current LiabilitesCDAY.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 1B 2B 3B 4B 5B

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 105.00% over the past year.
Measured over the past years, CDAY shows a quite strong growth in Earnings Per Share. The EPS has been growing by 19.61% on average per year.
CDAY shows a strong growth in Revenue. In the last year, the Revenue has grown by 21.63%.
The Revenue has been growing by 13.19% on average over the past years. This is quite good.
EPS 1Y (TTM)105%
EPS 3Y19.61%
EPS 5YN/A
EPS Q2Q%85%
Revenue 1Y (TTM)21.63%
Revenue growth 3Y14.78%
Revenue growth 5Y13.19%
Sales Q2Q%19.61%

3.2 Future

The Earnings Per Share is expected to grow by 42.72% on average over the next years. This is a very strong growth
CDAY is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 17.41% yearly.
EPS Next Y76.11%
EPS Next 2Y49.35%
EPS Next 3Y40.92%
EPS Next 5Y42.72%
Revenue Next Year22.54%
Revenue Next 2Y18.66%
Revenue Next 3Y17.44%
Revenue Next 5Y17.41%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
CDAY.CA Yearly Revenue VS EstimatesCDAY.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
CDAY.CA Yearly EPS VS EstimatesCDAY.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 2 4 6

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 55.26 indicates a quite expensive valuation of CDAY.
CDAY's Price/Earnings ratio is a bit cheaper when compared to the industry. CDAY is cheaper than 62.50% of the companies in the same industry.
CDAY's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.30.
CDAY is valuated quite expensively with a Price/Forward Earnings ratio of 39.59.
87.50% of the companies in the same industry are more expensive than CDAY, based on the Price/Forward Earnings ratio.
CDAY is valuated expensively when we compare the Price/Forward Earnings ratio to 21.76, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 55.26
Fwd PE 39.59
CDAY.CA Price Earnings VS Forward Price EarningsCDAY.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CDAY is valued a bit cheaper than the industry average as 62.50% of the companies are valued more expensively.
CDAY's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 198.43
EV/EBITDA 51.25
CDAY.CA Per share dataCDAY.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

CDAY's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CDAY's earnings are expected to grow with 40.92% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.73
PEG (5Y)N/A
EPS Next 2Y49.35%
EPS Next 3Y40.92%

0

5. Dividend

5.1 Amount

CDAY does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CERIDIAN HCM HOLDING INC

TSX:CDAY (3/20/2024, 7:00:00 PM)

92.28

+0.34 (+0.37%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryProfessional Services
Earnings (Last)N/A N/A
Earnings (Next)02-08 2022-02-08
Inst Owners85.76%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap14.41B
Analysts76.67
Price Target105.21 (14.01%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)14.89%
Min EPS beat(2)7.19%
Max EPS beat(2)22.6%
EPS beat(4)3
Avg EPS beat(4)28.5%
Min EPS beat(4)-3.23%
Max EPS beat(4)87.42%
EPS beat(8)7
Avg EPS beat(8)52.78%
EPS beat(12)11
Avg EPS beat(12)42.08%
EPS beat(16)14
Avg EPS beat(16)46.25%
Revenue beat(2)2
Avg Revenue beat(2)0.09%
Min Revenue beat(2)0.09%
Max Revenue beat(2)0.09%
Revenue beat(4)4
Avg Revenue beat(4)0.54%
Min Revenue beat(4)0.09%
Max Revenue beat(4)1.34%
Revenue beat(8)7
Avg Revenue beat(8)0.44%
Revenue beat(12)10
Avg Revenue beat(12)0.86%
Revenue beat(16)11
Avg Revenue beat(16)0.39%
PT rev (1m)0%
PT rev (3m)0.83%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.06%
EPS NY rev (1m)0%
EPS NY rev (3m)0.31%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 55.26
Fwd PE 39.59
P/S 7.32
P/FCF 198.43
P/OCF 61.94
P/B 4.68
P/tB N/A
EV/EBITDA 51.25
EPS(TTM)1.67
EY1.81%
EPS(NY)2.33
Fwd EY2.53%
FCF(TTM)0.47
FCFY0.5%
OCF(TTM)1.49
OCFY1.61%
SpS12.6
BVpS19.71
TBVpS-2.16
PEG (NY)0.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.04%
ROE 0.18%
ROCE 3.18%
ROIC 2.29%
ROICexc 2.68%
ROICexgc 16.01%
OM 7.74%
PM (TTM) 0.28%
GM 42.19%
FCFM 3.69%
ROA(3y)-0.66%
ROA(5y)-0.4%
ROE(3y)-2.35%
ROE(5y)-1.42%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-5.28%
GM growth 5Y-0.66%
F-Score8
Asset Turnover0.16
Health
Industry RankSector Rank
Debt/Equity 0.53
Debt/FCF 22.77
Debt/EBITDA 5.48
Cap/Depr 108.46%
Cap/Sales 8.13%
Interest Coverage 250
Cash Conversion 77.56%
Profit Quality 1337.5%
Current Ratio 1.09
Quick Ratio 1.09
Altman-Z 1.17
F-Score8
WACC8.14%
ROIC/WACC0.28
Cap/Depr(3y)101.27%
Cap/Depr(5y)94.3%
Cap/Sales(3y)6.97%
Cap/Sales(5y)6.61%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)105%
EPS 3Y19.61%
EPS 5YN/A
EPS Q2Q%85%
EPS Next Y76.11%
EPS Next 2Y49.35%
EPS Next 3Y40.92%
EPS Next 5Y42.72%
Revenue 1Y (TTM)21.63%
Revenue growth 3Y14.78%
Revenue growth 5Y13.19%
Sales Q2Q%19.61%
Revenue Next Year22.54%
Revenue Next 2Y18.66%
Revenue Next 3Y17.44%
Revenue Next 5Y17.41%
EBIT growth 1Y376.6%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year136.31%
EBIT Next 3Y51.44%
EBIT Next 5Y42.35%
FCF growth 1Y159.51%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y699.3%
OCF growth 3Y37.87%
OCF growth 5YN/A